Clinical Trials Browser

Phase 1/2 × Enrolling by invitation × Lenalidomide × Clear all

NCT07210047 2025-10-07

Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients

Phase 1/2 Enrolling by invitation

Multiple Myeloma

NCT06762431 2025-01-07

VTB-CLL002

Phase 1/2 Enrolling by invitation

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell